In the latter case, since BCL2 expression is observed to be driven by ASCL1 and higher in SCLC-A [19,28,188], it is possible that cells with low BCL2 have alternate resistance mechanisms, especially those driven by subtype transformation. The gene discussed is BCL2; the disease is small cell lung carcinoma.